Laguna Pharmaceuticals

About:

Laguna Pharmaceuticals is a biopharmaceutical company advancing vanoxerine for the treatment of atrial fibrillation.

Top Investors: JumpStart, Versant Ventures, Frazier Healthcare Partners, Sante Ventures, BioMed Ventures

Description:

ChanRx Corp. intends to develop and market small molecule pharmaceuticals to treat atrial fibrillation, a common arrhythmia that can cause heart attacks and strokes. The company was founded in 2008 and is based in Cleveland, Ohio.

Total Funding Amount:

$37.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2006-01-01

Founders:

Howard C. Dittrich

Number of Employees:

1-10

Last Funding Date:

2015-07-30

IPO Status:

Private

Industries: